Awaiting development: Guidance and quality standards

Showing 71 to 80 of 335

Guidance and quality standards awaiting development
Title	Type
Digital platforms to support cardiac rehabilitation	Health technology evaluation
Digital platforms to support self-management of asthma : early value assessment	Health technology evaluation
Digital support for children and young people with eating disorders:early value assessment	Health technology evaluation
Digital technologies to support smoking cessation in secondary care patients: early value assessment	Health technology evaluation
Diverticular disease	Quality standard
Donidalorsen for preventing hereditary angioedema attacks in people 12 years and over ID6457	Technology appraisal guidance
Dostarlimab and docetaxel for treating advanced non-small-cell lung cancer after anti-PD-L1 treatment and chemotherapy TS ID 12115	Technology appraisal guidance
Dostarlimab with chemotherapy for untreated and with niraparib for maintenance treatment of advanced non-mucinous epithelial ovarian, fallopian tube or primary peritoneal cancer [ID6311]	Technology appraisal guidance
Dostarlimab with platinum-based chemotherapy for treating advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency (MA review of TA963) [ID6426]	Technology appraisal guidance
Doxecitine–doxribtimine for treating thymidine kinase 2 deficiency in people of any age who had symptoms before 13 years ID6484	Technology appraisal guidance